1.62 would be sick!
But that would require a monster quarter with revenue will upwards of $30m ($47m is what the Company projected for the entire year so...) Who knows how they will report the KannaLife or CannaVest numbers, as they may not be realized yet or amortized through the year.
Possible positive signs from upcoming earnings will be forward looking statements regarding domestic and European expansion. Since these revenues are so new it's hard to project numbers and know market cycles so early in the game. For example, the 2013 Denver Cannabis Cup could be a major windfall in April but you can't really know how much revenue will be made. However, this years first ever cup should be a good benchmark for future guidance and as the MJ industry expands, who knows maybe the 2014 2nd Annual Denver Cannabis Cup will be another blockbuster sell out!
Back to 1.62 though, that's a $1.5b market cap which is quite generous. Even if MJNA reported a $50m blowout, that's still a rich valuation. Nevertheless, if you can hold for a year or 2, and the chips fall into place, this stock could be $5 easy. And uplisting would be nice followed by institutional backing for drug trials and I dare speculate a $10b market cap could be achievable.
News 
Market Data 
Discover 
AI
